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Background
The cellular and molecular pathways driving synovial
inflammation and stromal remodeling in spondyloarthritis
(SpA) remain largely unknown. As SpA and rheumatoid
arthritis (RA) show clearly distinct patterns of structural
remodelling, we conducted this study to identify pathways
specific for SpA synovitis by an unbiased microarray
screening approach of the inflamed synovial tissue in both
conditions.
Materials and methods
Synovial tissue samples were obtained by arthroscopy
from untreated individuals with SpA, RA and gout. RNA
was extracted and gene expression profiling was per-
formed. Top differentially expressed genes were validated
on three independent cohorts of SpA versus control sam-
ples by qPCR and immunohistochemistry. qPCR was also
performed on paired SpA synovial biopsies before and
after TNF blockade.
Results
The microarray experiments identified a signature set of
359 genes that discriminated with high certainty between
SpA and RA patients. Both, technical validation by qPCR
on the same samples, and biological validation in an
independent cohort of early, untreated SpA and RA
yielded a strong correlation between the microarray and
qPCR data. The gene signature was also consistent as
pathway analysis revealed thatt o p - r a n k i n gu p r e g u l a t e d
transcripts in SpA were related to myocyte/myofibroblast
biology. Several of these genes, including alpha smooth
muscle actin (aSMA), showed up to 100-fold upregula-
tion in SpA versus RA. Analysis of gout versus SpA sam-
ples confirmed that these genes were specifically
upregulated in SpA synovitis rather than downregulated
in RA. Immunohistochemistry for aSMA identified
increased expression in SpA versus RA in the intimal lin-
ing and synovial sublining layers. Double immunofluores-
cence and FACS analyses revealed a colocalization of
aSMA and fibroblasts marker CD90. Finally, paired ana-
lysis of SpA samples before and after TNF blockade
showed that the expression of these genes was not
altered.
Conclusions
This study identified a robust and disease-specific increase
in myofibroblasts in SpA synovitis. The reason for this
increase and the potential role of these cells in inflamma-
tion and, more importantly, structural remodelling in SpA
are currently under investigation.
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